“ASSESSMENT OF CARDIOVASCULAR AND RENAL OUTCOMES FOLLOWING DAPAGLIFLOZIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE” (2026) Asian Journal of Medical Research and Health Sciences, 4(2), pp. 1398–1403. doi:10.65605/a-jmrhs.2026.v04.i02.pp1398-1403.